MyCODE: A prospective evaluation of Lay-language Molecular Tumor Board Protocols in Precision Oncology

Providing patients with lay-language MTB protocols is feasible, accepted, and valued even in the absence of therapeutic options. The MyCODE approach seems to enable patient empowerment and to support patients and physicians in shared decision-making in precision oncology.